Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for poly( adp- ribose) polymerase inhibitor
Most Correlated Studies
- Lymphoblastoid B cells treated with olaparib to inhibit poly(ADP-ribose) polymerase (PARP)
- Acute myeloid leukemia C1498 cells treated with PARP1 inhibitor PJ-34
- Breast cancer cerebral xenografts treated with carboplatin and ABT888
- Prostate stromal WPMY1 cells grown in complete or androgens-deprived media with or without Olaparib
- Burkitt lymphoma DG-75 cells expressing EBV LMP1 and treated with olaparib
Most Relevant Literature
- Design and Preclinical Evaluation of a Novel B7-H4-Directed Antibody-Drug Conjugate, AZD8205, Alone …
- Validation of the use of a fluorescent PARP1 inhibitor for the detection of oral, oropharyngeal and …
- Poly (ADP-ribose) polymerase 1 (PARP1) inhibition promotes pulmonary metastasis of osteosarcoma by b…
- Phosphoproteome and drug-response effects mediated by the three protein phosphatase 2A inhibitor pro…
- Genome-wide and high-density CRISPR-Cas9 screens identify point mutations in PARP1 causing PARP inhi…
Most Relevant Clinical Trials
- Study of Poly (ADP-Ribose) Polymerase (PARP) Inhibitor E7016 in Combination With Temozolomide in Sub…
- A Study Of Poly (ADP-Ribose) Polymerase Inhibitor PF-01367338 In Combination With Several Chemothera…
- A Study to Evaluate the Effectiveness and Tolerability of a Second Maintenance Treatment in Particip…
- Phase 2 Study of the Poly(ADP-Ribose) Polymerase Inhibitor E7016 in Combination With Temozolomide in…
- A Study of INO-1001, an Intravenous PARP (Poly [ADP Ribose] Polymerase) Inhibitor in Acute Heart Att…
